| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/23/2002 | CA2428782A1 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and its method of preparation |
| 05/23/2002 | CA2428753A1 Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 05/23/2002 | CA2428189A1 Pharmaceutival preparations comprising corticosteroids and antiinfective agents |
| 05/22/2002 | EP1207164A2 Method for producing a powder containing crystalline maltitol particles |
| 05/22/2002 | EP1206943A1 Matrix adhering to nasal mucosa |
| 05/22/2002 | EP1206942A1 Water channel opener compositions and medicinal compositions for ophthalmic use |
| 05/22/2002 | EP1206928A1 Water-containing powder composition, process for producing the same, and cosmetic preparation containing the powder composition |
| 05/22/2002 | EP1206485A2 New effectors of dipeptidyl peptidase iv for topical use |
| 05/22/2002 | EP1206466A1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 05/22/2002 | EP1206290A1 Cyclodextrin containing pressure sensitive adhesives |
| 05/22/2002 | EP1206285A2 Drug-carrier complexes and methods of use thereof |
| 05/22/2002 | EP1206284A1 Method for delivery of therapeutic agents using a solution of dextrin |
| 05/22/2002 | EP1206283A2 Improved cellular uptake of bioactive agents |
| 05/22/2002 | EP1206282A1 Film forming polymers, methods of use, and devices and applications thereof |
| 05/22/2002 | EP1206281A1 Moxifloxacin formulation containing common salt |
| 05/22/2002 | EP1206280A1 Edible holographic products, particularly pharmaceuticals and methods and apparatus for producing same |
| 05/22/2002 | EP1206275A2 Irrigation solution and method for inhibition of pain and inflammation |
| 05/22/2002 | EP1206268A1 Novel compositions for controlled release of a biologically active agent, and the preparation thereof |
| 05/22/2002 | EP1206266A2 Formulations for parenteral use of estramustine phosphate and albumin |
| 05/22/2002 | EP1206258A1 Compositions containig esthers for treating parasitic infestations of organisms |
| 05/22/2002 | EP1206254A1 Drug releasing biodegradable fiber implant |
| 05/22/2002 | EP1206253A1 Pharmaceutical preparation containing nanosol |
| 05/22/2002 | EP1206252A1 Amplification of folate-mediated targeting to tumor cells using polymers |
| 05/22/2002 | EP1206251A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles |
| 05/22/2002 | EP1206250A2 Pharmaceutical formulations with different release times |
| 05/22/2002 | EP1206249A1 Hydrodynamically balancing oral drug delivery system |
| 05/22/2002 | EP1206248A2 Controlled-release sedative-hypnotic compositions and methods related thereto |
| 05/22/2002 | EP1206247A1 Floating pharmaceutical composition comprising an active phase and a non-active phase |
| 05/22/2002 | EP1206246A1 Means for creating a mass having structural integrity |
| 05/22/2002 | EP1206245A2 Phospholipid gel |
| 05/22/2002 | EP1206244A2 Aqueous pharmaceutical composition containing moxifloxacin or salts thereof |
| 05/22/2002 | EP1206243A1 Implantable drug delivery catheter system with capillary interface |
| 05/22/2002 | EP1206189A1 Rotavirus vaccine formulations |
| 05/22/2002 | EP1152776B1 Biodegradable, injectable oligomer-polymer composition |
| 05/22/2002 | EP1109558B1 Sustained release ranolazine formulations |
| 05/22/2002 | EP1102581B1 A microemulsion forming composition for the sustained release of an active agent |
| 05/22/2002 | EP1089722B1 Matrix-type transdermal patch for steroid hormones |
| 05/22/2002 | EP1049487B1 Treatment of acute intermittent porphyria (aip) and other porphyric diseases |
| 05/22/2002 | EP1014940B1 Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent |
| 05/22/2002 | EP0943138B1 Flat transdermal medicated self-adhesive patch |
| 05/22/2002 | EP0902681B1 Inhibition of selectin binding |
| 05/22/2002 | EP0859554B1 Aromatic granulated material |
| 05/22/2002 | EP0810822B1 Use of aerogels in agriculture |
| 05/22/2002 | EP0797431B1 Aerosol formulations of peptides and proteins |
| 05/22/2002 | EP0746329B1 Anti-inflammatory factor containing compositions, method of production, and use |
| 05/22/2002 | EP0662097B1 Polymer composition |
| 05/22/2002 | EP0650353B1 Palatable pharmaceutical compositions |
| 05/22/2002 | CN2492228Y 'Sanjiao' tablet |
| 05/22/2002 | CN1350475A Method and device for forming particles |
| 05/22/2002 | CN1350465A Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetiques |
| 05/22/2002 | CN1350456A Pharmaceutical compositions comprising a pyrimidine derivative and cyclodextrin |
| 05/22/2002 | CN1350451A 贴剂 Patch |
| 05/22/2002 | CN1350450A Fast-dispersing dosage forms containing fish gelatin |
| 05/22/2002 | CN1350436A Solid delivery systems for aroma ingredients |
| 05/22/2002 | CN1349826A Lingguo extract capsule and its prepn. method |
| 05/22/2002 | CN1349821A Pharyngitis treating Chinese medicine plaster |
| 05/22/2002 | CN1349818A Effective part group in red sage mixture and its delayed release prepn. medicinal use and prepn process |
| 05/22/2002 | CN1349812A Composite medicine for treating myocardosis and its prepn |
| 05/22/2002 | CN1349808A Externally applied cancer treating foamed ointment |
| 05/22/2002 | CN1349800A Ointment for treating traumatic injury, setting fracture and eliminating swelling |
| 05/22/2002 | CN1349794A Preparation absorbed through skin |
| 05/22/2002 | CN1085095C Preparation method of medicine Huanshen xingnao for curing encephalomyelopathy |
| 05/22/2002 | CN1085092C Technology for producing comedo eliminating liquid |
| 05/22/2002 | CN1085087C External used ointment for curing dermatosis, venereal disease and AIDS and preparation method thereof |
| 05/22/2002 | CN1085086C Capsule for treatment of AIDS and preparing mehtod thereof |
| 05/22/2002 | CN1085077C Far infrared plaster |
| 05/22/2002 | CN1085076C Prevention of leakage during thermotropic phase transition in liposomes and biological cells |
| 05/22/2002 | CN1085048C Microemulsion |
| 05/21/2002 | US6392063 Hydrolysis-promoting hydrophobic taxane derivatives |
| 05/21/2002 | US6392036 Sanitizing particles in sample; obtain sample, expose to heat, monitor sample for antiseptic nature |
| 05/21/2002 | US6391924 Taurine derivatives useable in the treatment of ophthalmic disorders |
| 05/21/2002 | US6391922 Administering neurotransmitter |
| 05/21/2002 | US6391904 Bone disorders |
| 05/21/2002 | US6391886 Oral compositions having improved consumer aesthetics |
| 05/21/2002 | US6391879 Therapeutic anti-fungal nail preparation |
| 05/21/2002 | US6391870 Dopaminergic agent |
| 05/21/2002 | US6391860 Skin disorders |
| 05/21/2002 | US6391849 Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis |
| 05/21/2002 | US6391832 Medical emulsion for lubrication and delivery of drugs |
| 05/21/2002 | US6391607 Human DNase I hyperactive variants |
| 05/21/2002 | US6391587 Nucleotide sequences for use in the prevention of microorganismal infections |
| 05/21/2002 | US6391452 Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations |
| 05/21/2002 | US6391343 Particle comprising fibrinogen bound on surface of albumin matrix, capable of co-aggregation with platelets, and of aggregation in solution containing soluble fibrinogen at concentration not capable of clot formation by itself |
| 05/21/2002 | US6391342 Oral pharmaceutical formulation comprising granules having inert core coated with inner layer comprising benzimidazole, disintegrant and surfactant in matrix of glyceride melt coating substance, intermediate layer, enteric outer layer |
| 05/21/2002 | US6391341 Stable pellets containing inert core with spherical symmetry and specified diameter made of starch and sucrose, coated with active layer containing micronized piroxicam and excipients, with polymeric insulating layer and with enteric layer |
| 05/21/2002 | US6391340 Dry powder pharmaceutical formulation |
| 05/21/2002 | US6391339 Administering pentasaccharide anticoagulant |
| 05/21/2002 | US6391338 System for rendering substantially non-dissoluble bio-affecting agents bio-available |
| 05/21/2002 | US6391337 Transforming acetaminophen and direct compression vehicle into a homogenous granulate under high shear conditions without degradation; microcystalline cellulose vehicle and lubricant |
| 05/21/2002 | US6391336 Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 05/21/2002 | US6391335 Effervescent drug delivery system for oral administration |
| 05/21/2002 | US6391334 Barrier-forming composition |
| 05/21/2002 | US6391330 Proanthocyanidins and ascorbic acid composition for topical application to human respiratory and oral mucosa |
| 05/21/2002 | US6391318 Composition comprising antigen and effective adjuvant amount of chitosan produced from chitin by deacetylation to degree of greater than 40% and having molecular weight between 10 kd and 500 kd |
| 05/21/2002 | US6391307 Composition comprising the lower, no-branch culm portion of bamboo |
| 05/21/2002 | US6391294 In situ formation of polymeric material |
| 05/21/2002 | US6391288 Microcapsule comprising inner oil phase comprising oil droplets with specified particle size, which are encapsulated in water phase comprising agar as hydrophilic polymer gelling agent, which is dispersed in outer oil phase |
| 05/21/2002 | US6391282 Topically administering antihistamine at sufficiently high active concentration to be effective in treatment of delayed allergic reactions caused by poison ivy and poison sumac or poison oak |
| 05/21/2002 | CA2330480C Controlled release formulation of divalproex sodium |
| 05/21/2002 | CA2119932C Pressurized hydrofluoroalkane pharmaceutical aerosol compositions |